Loading...
XSHG
603079
Market cap413mUSD
Jul 09, Last price  
17.54CNY
1D
-0.79%
1Q
5.22%
IPO
43.84%
Name

Zhejiang Shengda Bio-pharm Co Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
4.08
EPS
—
Div Yield, %
0.34%
Shrs. gr., 5y
1.62%
Rev. gr., 5y
8.10%
Revenues
727m
-1.44%
449,254,400398,770,700380,897,097536,429,474482,147,681508,561,120492,709,861519,149,812867,314,752789,732,754738,019,050727,405,727
Net income
-54m
L
52,360,20054,591,70043,785,14686,702,93760,935,61572,610,20244,544,42547,030,263197,438,34075,756,47331,484,427-54,062,930
CFO
64m
+58.22%
110,080,900105,279,80034,401,628148,071,83973,001,50495,334,03188,685,91258,553,623333,201,87574,460,43940,717,54664,421,472
Dividend
Jun 12, 20240.06 CNY/sh

Profile

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives worldwide. The company offers vitamins, such as biotin and folic acid, etc.; biological fresh-keeping agents, including nisin and natamycin; and intermediate APIs. It also produces natural food preservatives. The company is based in Tiantai, China.
URL
https://www.sd-pharm.com/
IPO date
Aug 23, 2017
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
727,406
-1.44%
738,019
-6.55%
Cost of revenue
717,185
671,873
Unusual Expense (Income)
NOPBT
10,220
66,146
NOPBT Margin
1.41%
8.96%
Operating Taxes
8,894
6,084
Tax Rate
87.02%
9.20%
NOPAT
1,326
60,062
Net income
(54,063)
-271.71%
31,484
-58.44%
Dividends
(10,271)
(23,966)
Dividend yield
0.42%
1.12%
Proceeds from repurchase of equity
(10,576)
BB yield
0.43%
Debt
Debt current
94,298
33,231
Long-term debt
144,304
609
Deferred revenue
5,464
7,583
Other long-term liabilities
1
Net debt
(98,833)
(347,578)
Cash flow
Cash from operating activities
64,421
40,718
CAPEX
(245,927)
Cash from investing activities
(241,519)
Cash from financing activities
176,980
FCF
(92,474)
28,653
Balance
Cash
326,736
320,718
Long term investments
10,700
60,700
Excess cash
301,066
344,517
Stockholders' equity
609,762
674,251
Invested Capital
1,212,687
1,026,245
ROIC
0.12%
5.92%
ROCE
0.67%
4.80%
EV
Common stock shares outstanding
168,947
171,189
Price
14.57
16.10%
12.55
-27.46%
Market cap
2,461,553
14.57%
2,148,421
-27.46%
EV
2,378,029
1,816,292
EBITDA
82,833
134,393
EV/EBITDA
28.71
13.51
Interest
1,834
4,559
Interest/NOPBT
17.95%
6.89%